Holding digital assets was once largely viewed as a passive strategy centered on long-term appreciation, inflation protection and portfolio diversification. Today, however, institutional investors are increasingly focused on a different objective: generating productive returns from digital asset holdings while maintaining the oversight, security and liquidity standards expected in traditional finance. That shift is driving growing […]

VERAXA Biotech (NASDAQ: VRXA) announced new in vitro proof-of-concept data supporting its novel BiTAC(TM)-ADC technology platform, which is designed to improve precision in cancer treatment through tumor-restricted activation of therapeutic agents. The company reported that BiTAC-ADCs demonstrated the ability to distinguish between breast cancer and healthy cells and achieved dose-dependent killing of 3D tumor cell spheroids while minimizing toxicity through the […]

Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. “Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur,” reads a recent article. “The company’s vision reflects a […]

VolitionRx Limited (NYSE American: VNRX) announced a collaboration with Sysmex (TYO: 6869) to optimize Volition’s Nu.Q® NETs H3.1 assay on the Sysmex diagnostic platform. The agreement supports Volition’s strategy of licensing its proprietary Nu.Q® NETs technology to established global diagnostics companies that can leverage their disease expertise, regulatory capabilities and installed analyzer base to accelerate development and commercialization. Volition said the collaboration has progressed beyond assay transfer and […]

ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional order for its DefendAir Net Pod system from a second business unit within a Tier-1 Israeli-based global defense company. The order is intended to support integration of the DefendAir Net Pod into the customer’s autonomous ground-based Counter-UAS platform and includes dedicated engineering integration services from […]

With a 2026 drilling window fast approaching and $70 million in fresh capital already secured, Greenland Energy (NASDAQ: GLND) is making a compelling argument that the Jameson Land Basin in East Greenland, one of the largest undeveloped Arctic hydrocarbon positions in the world, is no longer a story about geological potential but about execution. In an updated investor […]

SpaceX (NASDAQ: SPCX) briefly surpassed Amazon.com in market capitalization on June 16 as investors continued piling into shares following the company’s record-setting initial public offering, according to a Reuters report. Reuters reported that shares of Elon Musk’s rocket, satellite and artificial intelligence company climbed as much as 10%, pushing its valuation above $2.7 trillion and, at one point, ahead of both Amazon […]

Humacyte (NASDAQ: HUMA) announced the pricing of an underwritten public offering of 47.6 million shares of common stock at $1.05 per share, with expected gross proceeds of approximately $50 million before underwriting discounts, commissions and offering expenses. The company also granted underwriters a 30-day option to purchase up to an additional 7.1 million shares at the public offering price. The offering is expected […]

Datavault AI (NASDAQ: DVLT) announced that its Dream Bowl I meme coin, a commemorative digital collectible tied to Dream Bowl XIV, is expected to begin trading on the Biconomy cryptocurrency exchange as early as June 23, 2026. The company said the anticipated listing would mark the latest Datavault AI-issued token to advance from issuance to live secondary-market trading and represents another step in expanding […]

VERAXA Biotech (NASDAQ: VRXA) is advancing a diversified oncology pipeline spanning monoclonal antibodies, antibody-drug conjugates, bispecific ADCs and proprietary BiTAC-based therapeutic formats across multiple cancer indications. “The company is focused on the discovery and development of a new generation of antibody-based therapeutics for the treatment of solid tumors. VERAXA’s vision is to deliver the next wave […]

Greenland Energy (NASDAQ: GLND) was featured in an analysis by BriefGlance.com and columnist Sarah Hughes examining the company’s appointment of aerospace entrepreneur and Sidus Space founder Carol Craig to its board of directors. The article highlighted Craig’s background in aerospace, satellite technology and systems engineering, framing the appointment as a strategic effort to bring advanced […]

Greenland Energy (NASDAQ: GLND) announced a partnership with Envoy Media Co., founded by Dr. Phil McGraw, to produce and distribute a six-episode docuseries chronicling the company’s Arctic exploration activities in Greenland. Hosted by McGraw and scheduled to premiere in late summer 2026, the series will follow Greenland Energy’s Jameson Land Basin project and planned East […]